Variability of Platelet-rich Plasma Preparations
Authors:
- John ApostolakosJAJohn Apostolakos
- Toshiaki HiroseTHToshiaki Hirose
- Mark P. CoteMCMark P. Cote
- Augustus D. MazzoccaAMAugustus D. Mazzocca
- 1 December 2013
- journal article
- review article
- Published by Wolters Kluwer Health in Sports Medicine and Arthroscopy Review
- Vol. 21 (4) , 186-190
Abstract
Platelet-rich plasma (PRP) as a clinical treatment for bone, muscle, tendon, and cartilage injury has gained popularity in the field of orthopedic sports medicine. The use of a patient's own blood is an appealing aspect of PRP treatment, as the resulting plasma preparation is considered relatively benign in comparison with more common, potentially caustic treatments such as corticosteroids and anesthetics. Although appealing, the autologous nature of PRP introduces variability to plasma preparations, creating challenges for both the researcher and the clinician. Differences in patients at the time of blood draw result in plasma preparations that vary within as well as between patients. This variability is compounded by the multitude of protocols and devices available for procuring PRP. The variability of components and its effects on dosage should be considered in single or consecutive treatments of PRP.Keywords
This publication has 41 references indexed in Scilit:
- Effect of Platelet-Rich Plasma on Growth and Antigenic Profile of Human Osteoblasts and Its Clinical ImpactJournal of Oral and Maxillofacial Surgery, 2012
- Platelet‐Rich Plasma: The PAW Classification SystemArthroscopy, 2012
- Platelet-Rich Plasma Differs According to Preparation Method and Human VariabilityJournal of Bone and Joint Surgery, 2012
- Strategies in Biologic Augmentation of Rotator Cuff Repair: A ReviewClinical Orthopaedics and Related Research, 2010
- Basic Principles of Platelet Biology and Clinical ImplicationsCirculation Journal, 2010
- Platelet-Rich PlasmaThe American Journal of Sports Medicine, 2009
- Growth factor delivery methods in the management of sports injuries: the state of playBritish Journal of Sports Medicine, 2007
- Megakaryocyte development and platelet productionBritish Journal of Haematology, 2006
- The molecular mechanisms that control thrombopoiesisJournal of Clinical Investigation, 2005
- Autologous platelets as a source of proteins for healing and tissue regenerationThrombosis and Haemostasis, 2004